Bagnasco, Diamante
Bagnasco, Diamante
STUDI UMANISTICI
Aspergillus-related diseases in a cohort of patients with severe asthma: A SANI single-center report
2021-01-01 Solidoro P.; Nicola S.; Ridolfi I.; Bucca C.; Heffler E.; Bagnasco D.; Canonica G.W.; Blasi F.; Paggiaro P.; Rolla G.; Brussino L.
Biomarkers in obstructive respiratory diseases: an update
2012-01-01 Braido, F; Bagnasco, D; Scichilone, N; Santus, P; Solidoro, P; Di Marco, F; Corsico, A; Canonica, GW
Comparing a fixed combination of budesonide/formoterol with other inhaled corticosteroid plus long-acting beta-agonist combinations in patients with chronic obstructive pulmonary disease: a review
2019-01-01 Solidoro P.; Patrucco F.; Bagnasco D.
One year of mepolizumab. Efficacy and safety in real-life in Italy
2019-01-01 Bagnasco D.; Caminati M.; Menzella F.; Milanese M.; Rolla G.; Lombardi C.; Bucca C.; Heffler E.; Paoletti G.; Testino E.; Manfredi A.; Caruso C.; Guida G.; Senna G.; Bonavia M.; Riccio A.M.; Canonica G.W.; Passalacqua G.
Real-life studies of biologics used in asthma patients: key differences and similarities to trials
2019-01-01 Heffler E.; Paoletti G.; Giorgis V.; Puggioni F.; Racca F.; Del Giacco S.; Bagnasco D.; Caruso C.; Brussino L.; Rolla G.; Canonica G.W.
Specific Therapy for T2 Asthma
2022-01-01 Bagnasco D.; Testino E.; Nicola S.; Melissari L.; Russo M.; Canevari R.F.; Brussino L.; Passalacqua G.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Aspergillus-related diseases in a cohort of patients with severe asthma: A SANI single-center report | 2021 | Solidoro P.; Nicola S.; Ridolfi I.; Bucca C.; Heffler E.; Bagnasco D.; Canonica G.W.; Blasi F.; Paggiaro P.; Rolla G.; Brussino L. | |
| Biomarkers in obstructive respiratory diseases: an update | 2012 | Braido, F; Bagnasco, D; Scichilone, N; Santus, P; Solidoro, P; Di Marco, F; Corsico, A; Canonica, GW | |
| Comparing a fixed combination of budesonide/formoterol with other inhaled corticosteroid plus long-acting beta-agonist combinations in patients with chronic obstructive pulmonary disease: a review | 2019 | Solidoro P.; Patrucco F.; Bagnasco D. | |
| One year of mepolizumab. Efficacy and safety in real-life in Italy | 2019 | Bagnasco D.; Caminati M.; Menzella F.; Milanese M.; Rolla G.; Lombardi C.; Bucca C.; Heffler E.; Paoletti G.; Testino E.; Manfredi A.; Caruso C.; Guida G.; Senna G.; Bonavia M.; Riccio A.M.; Canonica G.W.; Passalacqua G. | |
| Real-life studies of biologics used in asthma patients: key differences and similarities to trials | 2019 | Heffler E.; Paoletti G.; Giorgis V.; Puggioni F.; Racca F.; Del Giacco S.; Bagnasco D.; Caruso C.; Brussino L.; Rolla G.; Canonica G.W. | |
| Specific Therapy for T2 Asthma | 2022 | Bagnasco D.; Testino E.; Nicola S.; Melissari L.; Russo M.; Canevari R.F.; Brussino L.; Passalacqua G. |